BIO-key International has repaid its $2.2M senior secured note in full, eliminating all long-term debt and has completed a $550,000 private placement of units at a premium to market. Each unit in the placement included one share of common stock or a prefunded warrant in lieu thereof and one common warrant to purchase one and one half shares of common stock at a presplit price of $0.175 per unit. Each common warrant is exercisable at a presplit price of $0.175 per share. Following the 1-for-18 reverse stock split effective with the commencement of trading on December 21, 2023, BIO-key will have approximately 1 million shares of common stock issued and outstanding and approximately 1.9 million common stock equivalents inclusive of prefunded warrants.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on BKYI:
- BIO-key announces 1-for-18 reverse stock split
- Following Stockholder Approval, BIO-key Announces 1-for-18 Reverse Stock Split to Regain Compliance with Nasdaq Minimum Bid Price Requirement
- Genesis HealthCare to add BIO-key’s PortalGuard IAM platform
- Genesis HealthCare System Builds on its Investment in BIO-key Biometric Authentication Security as it Migrates to Epic Hyperdrive
- BIO-key enters partnership with Ping Identity